Royal DSM's $360M Kensey Nash bid will close in a few days; MIT scientists creating sharper ultrasound imaging tech;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: Our coverage of the 2012 BIO International Convention continues. Roundup | Follow @MarkHFierce

> The rise in molecular diagnostics testing helped contribute to 96,000 biosciences jobs created in the U.S. from 2001 through 2010, even as private-sector jobs otherwise declined, according to a new report from the Biotechnology Industry Organization and the research firm Batelle. Story

> Investors are driving D. Medical Industries shares higher after the Israeli company disclosed it is negotiating to possibly buy a diabetes devices company. Item

> Venture capitalists are increasingly turning to startups that make smartphone and tablet apps for doctor and hospital use, Bloomberg reports. Story

> AdeTherapeutics, a developer of products designed to reduce post-surgical adhesion complications, has hired a number of renowned physicians for its "clinical execution team." Release

> Massachusetts Institute of Technology researchers are working on developing sharper ultrasound imaging technology in a bid to improve the diagnostic tool. Story

Biotech News

@FierceBiotech: The Fierce team has landed in Boston. Check out our dedicated BIO2012 page. Special Coverage | Follow @FierceBiotech

@JohnCFierce: Thanks to Bernard Munos, Jim Burns, Jason Gardner, Jill Milne, Mene Pangalos and 300+ of my closest friends for a great conversation this a.m. | Follow @JohnCFierce

@RyanMFierce: Danish biotech Nuevolution snagged €11 Million in new financing round. Release | Follow @RyanMFierce

> Millennium wants to rival top 10 drugmakers in oncology. Story

> E&Y: Biotech looks stable, but warning signs cloud the future. Article

> Novartis, Emergent headline $400M HHS plan to combat health threats. News

> Roche, Seaside join forces against autism and Fragile X. More

> Biotech beats overall economy in jobs report. Item

Pharma News

@FiercePharma: Will Human Genome's bid deadline backfire? Or will GSK be thwarted by some secretive white knight? Report | Follow @FiercePharma

> With Brennan gone, AstraZeneca megamerger talk can resume. Article

> No overtime for pharma reps, Supreme Court says. Story

> Merck Serono's final answer: Geneva HQ will close. News


Biotech Research News

> In life sciences R&D, China is reaching for the stars. Editor's corner

> Pluristem's placental stem cells spur bone marrow growth. Story

> Genetic markers uncovered for rare children's brain tumor. Report

> Breakthrough: Human Microbiome Project maps healthy body microbes. More

Pharma Manufacturing News

> Amneal Pharmaceuticals quadruples manufacturing. Item

> Just about everyone agrees: drug shortages are a complex puzzle. Story

> Canadian Internet pharmacy leader faces federal charges. Article

And Finally... Royal DSM's ($DSM) plans to pay $360 million for Kensey Nash ($KNSY), a regenerative medicine-focused medical device company, and looks to close its offer within a few days. Release

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.